Resveratrol and Stroke: from Chemistry to Medicine

被引:33
作者
Nabavi, Seyed Fazel [1 ]
Li, Huige [2 ]
Daglia, Maria [3 ]
Nabavi, Seyed Mohammad [1 ]
机构
[1] Baqiyatallah Univ Med Sci, Appl Biotechnol Res Ctr, Tehran, Iran
[2] Johannes Gutenberg Univ Med Ctr, Dept Pharmacol, D-55131 Mainz, Germany
[3] Univ Pavia, Dept Drug Sci, Med Chem & Pharmaceut Technol Sect, I-27100 Pavia, Italy
关键词
Antioxidants; neuroprotection; oxidative stress; polyphenol; resveratrol; stroke; INDUCED OXIDATIVE STRESS; NITRIC-OXIDE; ANTIHEMOLYTIC ACTIVITIES; MOLECULAR TARGETS; ISCHEMIC-STROKE; PICEID ISOMERS; HEART-DISEASE; RISK-FACTORS; CELL-DEATH; IN-VITRO;
D O I
10.2174/1567202611666140912114833
中图分类号
R74 [神经病学与精神病学];
学科分类号
100204 [神经病学];
摘要
Stroke is one of the most common cardiovascular diseases and is known as a leading cause of death in the world. Despite to its high prevalence, there are limited effective therapeutic strategies for stroke till now. However, oxidative stress plays an important role in the pathogenesis of stroke and therefore, antioxidant therapy could be used as a new therapeutic strategy. Among the antioxidants, some natural compounds are very interesting due to their low adverse effects. Resveratrol (3, 5, 4'-trihydroxystilbene) is a natural polyphenolic antioxidant found in grape skin, grape products, and peanuts as well as in red wine. In recent years, much attention has been paid to resveratrol due to its wide range of antioxidant actions. Resveratrol possesses cardioprotective actions through stimulation of nitric oxide production as well as antioxidative and anti-inflammatory effects. Here we review the available literatures on beneficial role of resveratrol on ischemic stroke. We also provide information about chemistry, sources, bioavailability, as well as clinical impacts of resveratrol.
引用
收藏
页码:390 / 397
页数:8
相关论文
共 78 条
[1]
Socioeconomic Status and Stroke An Updated Review [J].
Addo, Juliet ;
Ayerbe, Luis ;
Mohan, Keerthi M. ;
Crichton, Siobhan ;
Sheldenkar, Anita ;
Chen, Ruoling ;
Wolfe, Charles D. A. ;
McKevitt, Christopher .
STROKE, 2012, 43 (04) :1186-1191
[2]
Aggarwal BB, 2004, ANTICANCER RES, V24, P2783
[3]
Antioxidant and Antihemolytic Activities of Ethanolic Extract of Flowers, Leaves, and Stems of Hyssopus officinalis L. Var. angustifolius [J].
Alinezhad, Heshmatollah ;
Azimi, Razieh ;
Zare, Mahboobeh ;
Ebrahimzadeh, Mohammad Ali ;
Eslami, Shahram ;
Nabavi, Seyed Fazel ;
Nabavi, Seyed Mohammad .
INTERNATIONAL JOURNAL OF FOOD PROPERTIES, 2013, 16 (05) :1169-1178
[4]
Oxidative stress and its role in the pathogenesis of ischaemic stroke [J].
Allen, C. L. ;
Bayraktutan, U. .
INTERNATIONAL JOURNAL OF STROKE, 2009, 4 (06) :461-470
[5]
Administration of resveratrol: What formulation solutions to bioavailability limitations? [J].
Amri, A. ;
Chaumeil, J. C. ;
Sfar, S. ;
Charrueau, C. .
JOURNAL OF CONTROLLED RELEASE, 2012, 158 (02) :182-193
[6]
[Anonymous], 2006, PHYTOCHEM ADV RES
[7]
Resveratrol: A review of preclinical studies for human cancer prevention [J].
Athar, Mohammad ;
Back, Jung Ho ;
Tang, Xmwel ;
Kim, Kwang Ho ;
Kopelovich, Levy ;
Bickers, David R. ;
Kim, Arianna L. .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 2007, 224 (03) :274-283
[8]
Multiple molecular targets of resveratrol: Anti-carcinogenic mechanisms [J].
Athar, Mohammad ;
Back, Jung Ho ;
Kopelovich, Levy ;
Bickers, David R. ;
Kim, Arianna L. .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2009, 486 (02) :95-102
[9]
Therapeutic potential of resveratrol:: the in vivo evidence [J].
Baur, Joseph A. ;
Sinclair, David A. .
NATURE REVIEWS DRUG DISCOVERY, 2006, 5 (06) :493-506
[10]
Resveratrol inhibits nitric oxide and TNF-α production by lipopolysaccharide-activated microglia [J].
Bi, XL ;
Yang, JY ;
Dong, YX ;
Wang, JM ;
Cui, YH ;
Ikeshima, T ;
Zhao, YQ ;
Wu, CF .
INTERNATIONAL IMMUNOPHARMACOLOGY, 2005, 5 (01) :185-193